iScience Interventional
Microcatheter and imaging technologies for ophthalmologists to deliver site-specific ocular therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
€10—15m (Dealroom.co estimates Jan 2012.)
Menlo Park California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$15.0m | Series C | ||
$20.0m | Series E | ||
$20.5m | Series F | ||
$5.1m | Early VC | ||
N/A | $5.3m | Debt | |
$3.0m | Early VC | ||
$2.8m | Early VC | ||
Total Funding | €60.4m |